These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 7688977
1. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome. Shackley P, McGuire A, Boyd PA, Dennis J, Fitchett M, Kay J, Roche M, Wood P. J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977 [Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women. Hwa HL, Yen MF, Lin CL, Ko TM, Hsieh FJ, Chen TH. J Eval Clin Pract; 2008 Apr; 14(2):191-7. PubMed ID: 18284525 [Abstract] [Full Text] [Related]
4. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group. Piggott M, Wilkinson P, Bennett J. J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485 [Abstract] [Full Text] [Related]
7. [Cost effectiveness analysis of prenatal screening of trisomy 21 by maternal serum markers (hCG)]. Seror V, Moatti JP, Muller F, Le Gales C, Boue A. J Gynecol Obstet Biol Reprod (Paris); 1992 Aug; 21(8):915-22. PubMed ID: 1491137 [Abstract] [Full Text] [Related]
8. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital. Lamlertkittikul S, Chandeying V. J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410 [Abstract] [Full Text] [Related]
9. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection]. Christiansen M, Larsen SO, Nørgaard-Pedersen B. Lakartidningen; 1997 Dec 17; 94(51-52):4898-902. PubMed ID: 9454010 [Abstract] [Full Text] [Related]
10. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome. Chang TC, Cheng HH. Med J Malaysia; 1994 Dec 17; 49(4):351-4. PubMed ID: 7545778 [Abstract] [Full Text] [Related]
11. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT. CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836 [Abstract] [Full Text] [Related]
12. Age-independent indices in second-trimester serum screening for Down's syndrome are useless. Zimmermann R, Reynolds TM, John R, Spencer K, Bartels I, Coombes E, Trevor S. Prenat Diagn; 1996 Jan 15; 16(1):79-82. PubMed ID: 8821858 [Abstract] [Full Text] [Related]
13. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland. Crossley JA, Aitken DA, Berry E, Connor JM. J Med Screen; 1994 Jul 15; 1(3):180-3. PubMed ID: 8790513 [Abstract] [Full Text] [Related]
15. [Health Council of Netherlands recommendation 'Serum screening for risk assessment of Down syndrome for all women' poorly supported]. Hamerlynck JV, Knuist M. Ned Tijdschr Geneeskd; 2001 Oct 20; 145(42):2014-7. PubMed ID: 11695097 [Abstract] [Full Text] [Related]
16. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM. J Med Screen; 1998 Oct 20; 5(3):115-9. PubMed ID: 9795869 [Abstract] [Full Text] [Related]